Literature DB >> 20933094

ErbB signaling in cardiac development and disease.

Pablo Sanchez-Soria1, Todd D Camenisch.   

Abstract

The ErbB family of receptor tyrosine kinases (RTKs) is a family of receptors that allow cells to interact with the extracellular environment and transduce signals to the nucleus that promote differentiation, migration and proliferation necessary for proper heart morphogenesis and function. This review focuses on the role of the ErbB family of receptor tyrosine kinases, and their importance in proper heart morphogenesis, as well as their role in maintenance and function of the adult heart. Studies from transgenic mouse models have shown the importance of ErbB receptors in heart development, and provide insight into potential future therapeutic targets to help reduce congenital heart defect (CHD) mortality rates and prevent disease in adults. Cancer therapeutics have also shed light to the ErbB receptors and signaling network, as undesired side effects have demonstrated their importance in adult cardiomyocytes and prevention of cardiomyopathies. This review will discuss ErbB receptor tyrosine kinases (RTK) in heart development and disease including valve formation and partitioning of a four-chambered heart as well as cardiotoxicity when ErbB signaling is attenuated in adults.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20933094      PMCID: PMC3032360          DOI: 10.1016/j.semcdb.2010.09.011

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  96 in total

1.  Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme.

Authors:  T D Camenisch; A P Spicer; T Brehm-Gibson; J Biesterfeldt; M L Augustine; A Calabro; S Kubalak; S E Klewer; J A McDonald
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

3.  Combined doxorubicin and paclitaxel in advanced breast cancer: effective and cardiotoxic.

Authors:  J Gehl; M Boesgaard; T Paaske; B Vittrup Jensen; P Dombernowsky
Journal:  Ann Oncol       Date:  1996-09       Impact factor: 32.976

4.  Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.

Authors:  Yi Zhang; Alejandro Wolf-Yadlin; Phillip L Ross; Darryl J Pappin; John Rush; Douglas A Lauffenburger; Forest M White
Journal:  Mol Cell Proteomics       Date:  2005-06-11       Impact factor: 5.911

5.  Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differential expression of erbB2 and erbB4 receptors.

Authors:  S Rohrbach; X Yan; E O Weinberg; F Hasan; J Bartunek; M A Marchionni; B H Lorell
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

6.  Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1.

Authors:  A E Lin; P H Birch; B R Korf; R Tenconi; M Niimura; M Poyhonen; K Armfield Uhas; M Sigorini; R Virdis; C Romano; E Bonioli; P Wolkenstein; E K Pivnick; M Lawrence; J M Friedman
Journal:  Am J Med Genet       Date:  2000-11-13

7.  Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion.

Authors:  Katashi Okoshi; Masaharu Nakayama; Xinhua Yan; Marina P Okoshi; Adam J T Schuldt; Mark A Marchionni; Beverly H Lorell
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

8.  Congestive heart failure during imatinib mesylate treatment.

Authors:  Gina Turrisi; Francesco Montagnani; Simone Grotti; Claudio Marinozzi; Leonardo Bolognese; Giammaria Fiorentini
Journal:  Int J Cardiol       Date:  2009-08-04       Impact factor: 4.164

9.  Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.

Authors:  Ole Johan Kemi; Marcello Ceci; Ulrik Wisloff; Serena Grimaldi; Paolo Gallo; Godfrey L Smith; Gianluigi Condorelli; Oyvind Ellingsen
Journal:  J Cell Physiol       Date:  2008-02       Impact factor: 6.384

10.  Germline KRAS mutations cause Noonan syndrome.

Authors:  Suzanne Schubbert; Martin Zenker; Sara L Rowe; Silke Böll; Cornelia Klein; Gideon Bollag; Ineke van der Burgt; Luciana Musante; Vera Kalscheuer; Lars-Erik Wehner; Hoa Nguyen; Brian West; Kam Y J Zhang; Erik Sistermans; Anita Rauch; Charlotte M Niemeyer; Kevin Shannon; Christian P Kratz
Journal:  Nat Genet       Date:  2006-02-12       Impact factor: 38.330

View more
  28 in total

1.  Transcriptional interpretation of the EGF receptor signaling gradient.

Authors:  Alisa Fuchs; Lily S Cheung; Enrica Charbonnier; Stanislav Y Shvartsman; George Pyrowolakis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  EGFs and ERBBs--brief history and prospects.

Authors:  David F Stern
Journal:  Semin Cell Dev Biol       Date:  2010-10-21       Impact factor: 7.727

3.  Investigation of the role of DNA methylation in the expression of ERBB2 in human myocardium.

Authors:  Adolfo Quiñones-Lombraña; Rachael Hageman Blair; Javier G Blanco
Journal:  Gene       Date:  2017-07-21       Impact factor: 3.688

Review 4.  How to make a heart valve: from embryonic development to bioengineering of living valve substitutes.

Authors:  Donal MacGrogan; Guillermo Luxán; Anita Driessen-Mol; Carlijn Bouten; Frank Baaijens; José Luis de la Pompa
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

5.  NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors.

Authors:  Takahito M Miyake; Sunila Pradeep; Emine Bayraktar; Elaine Stur; Katelyn F Handley; Sherry Y Wu; Cristian Rodriguez-Aguayo; Ju-Seog Lee; Gabriel Lopez-Berestein; Robert L Coleman; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2020-06-04       Impact factor: 6.261

6.  Changes in gene expression within the extended amygdala following binge-like alcohol drinking by adolescent alcohol-preferring (P) rats.

Authors:  William J McBride; Mark W Kimpel; Jeanette N McClintick; Zheng-Ming Ding; Howard J Edenberg; Tiebing Liang; Zachary A Rodd; Richard L Bell
Journal:  Pharmacol Biochem Behav       Date:  2013-12-16       Impact factor: 3.533

7.  Integrative functional analysis of super enhancer SNPs for coronary artery disease.

Authors:  Juexiao Gong; Chuan Qiu; Dan Huang; Yiyan Zhang; Shengyong Yu; Chunping Zeng
Journal:  J Hum Genet       Date:  2018-02-28       Impact factor: 3.172

8.  Effects of radiation on the epidermal growth factor receptor pathway in the heart.

Authors:  Vijayalakshmi Sridharan; Sunil K Sharma; Eduardo G Moros; Peter M Corry; Preeti Tripathi; Benjamin J Lieblong; Chandan Guha; Martin Hauer-Jensen; Marjan Boerma
Journal:  Int J Radiat Biol       Date:  2013-04-16       Impact factor: 2.694

9.  The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction.

Authors:  Saghir Akhtar; Ibrahim Fadil Benter
Journal:  Bioimpacts       Date:  2013-01-26

10.  Rare copy number variants and congenital heart defects in the 22q11.2 deletion syndrome.

Authors:  Elisabeth E Mlynarski; Michael Xie; Deanne Taylor; Molly B Sheridan; Tingwei Guo; Silvia E Racedo; Donna M McDonald-McGinn; Eva W C Chow; Jacob Vorstman; Ann Swillen; Koen Devriendt; Jeroen Breckpot; Maria Cristina Digilio; Bruno Marino; Bruno Dallapiccola; Nicole Philip; Tony J Simon; Amy E Roberts; Małgorzata Piotrowicz; Carrie E Bearden; Stephan Eliez; Doron Gothelf; Karlene Coleman; Wendy R Kates; Marcella Devoto; Elaine Zackai; Damian Heine-Suñer; Elizabeth Goldmuntz; Anne S Bassett; Bernice E Morrow; Beverly S Emanuel
Journal:  Hum Genet       Date:  2016-01-07       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.